S. Sulovic

Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study

F. Meric-Bernstam, F. Janku, A. Naing, 2022, Journal of immunotherapy and precision oncology.

Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study

F. Meric-Bernstam, F. Janku, A. Naing, 2021, Investigational New Drugs.

1124P Phase Ib study to evaluate the safety of selinexor (SEL) in combination with pembrolizumab (PEM) in patients with advanced malignancies- the: The melanoma experience

F. Meric-Bernstam, F. Janku, A. Naing, 2020 .